determin
aetiolog
respiratori
complaint
immunosuppress
patient
seriou
matter
neutropen
fever
cancer
patient
associ
inhospit
mortal
respiratori
viral
infect
haematopoiet
stem
cell
transplant
may
lead
wors
outcom
establish
prompt
diagnosi
lead
expedit
treatment
appropri
antimicrobi
avoid
complic
associ
unnecessari
diagnost
test
treatmentrel
toxic
bronchoscopi
valuabl
instrument
evalu
pulmonari
infiltr
unknown
aetiolog
immunocompromis
patient
although
well
toler
patient
benign
procedur
potenti
complic
includ
hypoxaemia
bleed
pneumothorax
know
patient
bronchoscopi
like
benefit
key
import
clinician
imag
give
clue
potenti
diagnost
yield
bronchoalveolar
lavag
bal
noninvas
laboratori
test
tremend
valuabl
mani
patient
bronchoscopi
entertain
noninvas
test
nasopharyng
np
respiratori
viral
panel
rvp
perform
use
pcr
assay
identifi
communityacquir
respiratori
virus
improv
sensit
compar
convent
viral
cultur
rvppcr
perform
aspir
wash
swab
nasopharynx
commerci
avail
multipl
vendor
remain
unknown
abil
np
rvppcr
detect
viral
infect
involv
lower
respiratori
tract
spars
data
current
exist
show
variabl
clinic
correl
np
rvppcr
bal
rvppcr
obtain
patient
accompani
articl
lachant
et
al
sought
evalu
find
np
rvppcr
compar
bal
rvppcr
research
perform
retrospect
chart
review
adult
immunosuppress
patient
bal
np
rvppcr
perform
within
day
abl
identifi
patient
met
criteria
period
singl
univers
medic
centr
institut
employ
filmarray
biofir
diagnost
inc
salt
lake
citi
ut
usa
multiplex
pcr
assay
detect
adenoviru
coronaviru
four
strain
human
metapneumoviru
rhinoviru
influenza
ab
respiratori
syncyti
viru
rsv
parainfluenza
viru
mycoplasma
pneumonia
chlamydia
pneumonia
bordetella
pertussi
patient
median
time
durat
np
bal
test
day
patient
virus
identifi
test
primari
find
studi
concord
np
bal
rvppcr
test
fals
neg
rate
np
rvppcr
patient
discord
test
neg
np
rvppcr
posit
bal
rvppcr
influenza
identifi
patient
np
specimen
secondari
find
increas
chanc
posit
bal
rvppcr
patient
winter
month
recipi
allogen
haematopoiet
stem
cell
transplant
find
support
firstlin
use
np
rvppcr
immunosuppress
patient
present
respiratori
symptom
addit
low
pretest
probabl
respiratori
infect
test
may
reduc
need
invas
test
obtain
posit
np
find
may
expedit
treatment
respiratori
viral
infect
rsv
influenza
signific
risk
morbid
patient
popul
effect
treatment
avail
base
seem
reason
recommend
np
rvppcr
prior
perform
bronchoscopi
bal
respiratori
viral
infect
suspect
howev
clinician
must
respect
risk
fals
neg
np
rvppcr
test
pursu
test
includ
bal
clinic
suspicion
high
studi
mani
limit
author
acknowledg
readili
small
number
patient
obtain
retrospect
observ
manner
offer
signific
limit
nonuniform
time
obtain
np
bal
sampl
also
present
challeng
durat
viral
shed
respiratori
tract
like
vari
patient
patient
like
fals
neg
np
rvppcr
due
prolong
time
obtain
np
bal
sampl
addit
given
highli
sensit
natur
pcr
studi
probabl
nonclin
relev
virus
discov
posit
result
interpret
unknown
studi
add
bodi
literatur
interpret
rvppcr
immunosuppress
patient
respiratori
ill
good
correl
test
obtain
np
compar
bal
fluid
although
fals
neg
exist
ultim
clinician
must
remain
agil
interpret
newli
avail
diagnost
assay
